Found 60 matching trials
Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
NAThis study will investigate the performance of physician readers trained to...
Location
Multiple Locations
Narcolepsy Protect Against Alzheimer's Disease?
NALinks between orexin and amyloid processes have been underlined recently. D...
Location
Montpellier University Hospital, Gui de Chauliac
Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
PHASE4This study is designed to determine the effectiveness of florbetapir (18F) ...
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
PHASE1This study will test two different doses of florbetapir F 18 to determine w...
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
N/AIn this study, a total of 60 AD patients with Aฮฒ deposition will beenrolled...
Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
PHASE2The primary aim of this study is to compare regional amyloid burden in Park...
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
PHASE2This study will explore the use of flortaucipir as a biomarker for chronic ...
Location
Banner Alzheimer's Institute
A Noval Tau Tracer in Young Onset Dementia
PHASE1Dementia is a clinical syndrome which characterized by progressive cognitiv...
Location
Multiple Locations
FluoroAv45 Imaging Research-in Alzheimer's Disease
PHASE2Rationale: improving the early detection of AD at prodromal pre-dementia st...
Location
university hospital of CAEN
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
N/AThe purpose of this research is to better understand how dementia affects a...
Location
The Healthy Aging & Alzheimer's Research Care Center - University of Chicago